1. Home
  2. VGNT vs GPCR Comparison

VGNT vs GPCR Comparison

Compare VGNT & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VGNT

Versigent PLC Ordinary Shares

N/A

Current Price

$48.56

Market Cap

3.3B

Sector

N/A

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$49.22

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VGNT
GPCR
Founded
N/A
2016
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.8B
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
VGNT
GPCR
Price
$48.56
$49.22
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$103.17
AVG Volume (30 Days)
835.8K
546.0K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.75
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.44
$18.26
52 Week High
$49.62
$94.90

Technical Indicators

Market Signals
Indicator
VGNT
GPCR
Relative Strength Index (RSI) 60.59 44.23
Support Level $39.37 $43.76
Resistance Level $49.62 $56.63
Average True Range (ATR) 1.75 2.26
MACD 0.14 -0.59
Stochastic Oscillator 79.30 19.49

Price Performance

Historical Comparison
VGNT
GPCR

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: